Scientific and ethical issues in equivalence trials

JAMA

Volumn 285, Issue 9, 2001, Pages 1206-1208

  Djulbegovic, Benjamin ^a   Clarke, Mike ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UK COCHRANE CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOEQUIVALENCE; CLINICAL TRIAL; EDITORIAL; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0035819920     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.9.1206     Document Type: Editorial

References (21)

1. Ethical issues in the design and conduct of randomized controlled trials
2. Abacavir-lamuvidine-zidovudine vs indinavir-lamuvidine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial
3. Discussion sections in reports of controlled trials published in five general medical journals: Islands in search of continents?
4. Medical ethics and controlled trials
5. Trials: The next 50 years
6. The uncertainty principle and industry-sponsored research
7. Improving the quality of reporting of randomized controlled trials: The CONSORT statement
8. Violation of the uncertainty principle in conduct of randomized controlled trials (RCTs) of erythropoietin (EPO)
9. Equipoise and the ethics of randomization
10. Equipoise and "the uncertainty principle" are not two mutually exclusive concepts
11. Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 1. Ethical and scientific issues
12. Declaration of Helsinki should be strengthened: For and against
13. From methodology to ethics and from ethics to methodology
14. Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 2. Practical issues and specific cases
15. Absence of evidence is not evidence of absence